ArticleCancer biology & therapy2011

Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2.

James W Antoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.